250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 15 Life Science VC (Venture Capital) Funds in Austria in January 2025

A list of 15 VC (Venture Capital) funds that invest in Life science startups based in Austria. We rank investors based on the number of investments they made in Life science companies from Austria. We update this investor list every month.

Top 15 Life Science VC (Venture Capital) Funds in Austria in January 2025

Investor Life Science Austria investments
xista science ventures 3
xista science ventures 3
Nina Capital 2
Longevitytech.fund 2
R42 Group 2
APEX Ventures 2
APEX Ventures 2
FastVentures 1
SOSV 1
HCVC 1
Pace Ventures 1
OrbiMed 1
Biogena 1
Polaris Partners 1
Lansdowne Investment Company Cyprus 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
xista science ventures VC Fund · Klosterneuburg, Niederosterreich, Austria
We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
Show more
Investment focus
  • Biotechnology, Medical, Software
  • Seed, Pre-Seed, Series A
  • Austria, Slovenia
Portfolio highlights
  • subdron — subdron focuses on data processing in underwater inspections and autonomous underwater navigation.
  • infrared.city — Redefine environmental simulations. Our bespoke AI models revolutionise performative design, slashing time, cost, and complexity. Access cutting-edge services effortlessly because innovation should be for everyone
  • VALANX Biotech — Protein conjugation. Specific, fast and cost effective.
xista science ventures VC Fund · Klosterneuburg, Niederosterreich, Austria · 3 investments in the past 12 months
We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
Show more
Investment focus
  • Biotechnology, Medical, Medical Device
  • Seed, Pre-Seed, Series A
  • Austria, France, Slovenia
Portfolio highlights
  • Syntropic — Syntropic is a medical device company that develops novel technologies that helps for the treatment of psychiatric diseases and the improvement of cognitive abilities.
  • G.ST Antivirals — G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals utilizes the viral dependency on the host cell metabolism and exploits this to design specific interventions counteracting viral nutrient supply.
  • HEPHAISTOS-Pharma — Hephaistos Pharma is a developing weapons firm. They provide services for oncology, immunotherapy, and cancer. An online inquiry form is available on the company's website.
Nina Capital VC Fund · Barcelona, Catalonia, Spain · 4 investments in the past 12 months
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more
Investment focus
  • Health Care, Artificial Intelligence, Software
  • Seed, Pre-Seed, Series A
  • United States, United Kingdom, Austria
Portfolio highlights
  • Noah Labs — Noah Labs is a compant that creates AI-powered software solutions for medical care and research that help diagnose, manage illnesses, and guide interventions.
  • Rivia — Integrated Clinical Trial Intelligence. Drive therapeutic evaluation and trial management with real-time insights.
  • Lillian Care — Lillian is building a nationwide network of health facilities in Germany.
Longevitytech.fund VC Fund · Prague, Hlavni mesto Praha, Czech Republic
Investing globally in technologies extending healthy lifespans
Show more
Investment focus
  • Biotechnology, Health Care, Personal Health
  • Seed, Convertible Note, Pre-Seed
  • United States, United Kingdom, The Netherlands
Portfolio highlights
  • Yuva Biosciences — Using cutting edge mitochondrial science to develop cosmeceuticals and pharmaceuticals.
  • MitoRx Therapeutics — Developing revolutionary mitochondrial-protective therapeutics which reverse mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration. MitoRx Therapeutics' first-in-class first-in-target platform has potential to arrest the progression of some of the most challenging diseases.
  • Rejuvenation Technologies — Rejuvenation Technologies is a biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres. The company is headquartered in Mountain View, California.
R42 Group VC Fund · Stanford, California, United States · 4 investments in the past 12 months
R42 Group is a venture fund and an institute which invents, invests and informs covering AI, deep science, 5G mobile, biotech and fintech.
Show more
Investment focus
  • Biotechnology, Health Care, Information Technology
  • Seed, Funding Round, Pre-Seed
  • United Kingdom, United States, Austria
Portfolio highlights
  • Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
  • xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
  • Senisca — Developing a new generation of senotherapeutic interventions to target the diseases and aesthetic signs of ageing.
APEX Ventures VC Fund · Vienna, Wien, Austria · 7 investments in the past 12 months
APEX Ventures is an early-stage venture capital fund that invests in start-ups grounded in unique and protectable technology. They provide support and resources and aims to develop their start-ups in their respective field. Their initial focus areas include digital media, business intelligence, cybersecurity, fintech, and the future of work.
Show more
Investment focus
  • Artificial Intelligence, Health Care, Software
  • Seed, Series A, Pre-Seed
  • Germany, United Kingdom, Austria
Portfolio highlights
  • GEMESYS — Gemesys creates a chip that functions similarly to the human brain in order to overcome processing constraints and empower AI with the hardware it needs to complete its destiny
  • HyperHeat — HyperHeat is a climate tech startup, that develops a breakthrough solution for zero-carbon industrial heat at very high temperatures.
  • TriLite Technologies — The world's smallest projection displays from TriLite take laser beam scanning technology to the next level, for augmented vision as light as the eyewear of today.
APEX Ventures VC Fund · Vienna, Wien, Austria · 6 investments in the past 12 months
APEX Ventures is a deep-tech and medical-focused venture capital firm.
Show more
Investment focus
  • Artificial Intelligence, Health Care, Software
  • Seed, Series A, Pre-Seed
  • Germany, United Kingdom, Austria
Portfolio highlights
  • GEMESYS — Gemesys creates a chip that functions similarly to the human brain in order to overcome processing constraints and empower AI with the hardware it needs to complete its destiny
  • HyperHeat — HyperHeat is a climate tech startup, that develops a breakthrough solution for zero-carbon industrial heat at very high temperatures.
  • TriLite Technologies — The world's smallest projection displays from TriLite take laser beam scanning technology to the next level, for augmented vision as light as the eyewear of today.
FastVentures VC Fund · Budapest, Budapest, Hungary
venture capital
Show more
Investment focus
  • Software, Biotechnology, Information Technology
  • Seed, Series A, Series B
  • Hungary, South Korea, United States
Portfolio highlights
  • Iskra — Iskra offers web3 gaming opportunities using blockchain and rewards its stakeholders based on their participation.
  • On Vacation — On Vacation is a chat-based concierge service where customers may get help making reservations and getting personalized and optimal tours from travel specialists.
  • NextChapter — NextChapter is a digital commerce platform that acquires and operates Coupang and Naver-based online native brands in Korea. NextChapter is backed by BlueRun Ventures/BRV Capital Management, Goodwater Capital, Klim Ventures, Fast Ventures and Sandbox Network.NextChapter was founded in 2021 by Joshua Kwon and Jay Chung and is headquarteredin Seoul, Korea.
SOSV VC Fund · Princeton, New Jersey, United States · 75 investments in the past 12 months
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Seed, Convertible Note, Pre-Seed
  • United States, India, United Kingdom
Portfolio highlights
  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
HCVC VC Fund · Paris, Ile-de-France, France · 7 investments in the past 12 months
HCVC is an early-stage Venture Capital firm backing hardtech companies worldwide. Beyond its fund, HCVC supports hardtech founders through Hardware Club, a selective global community of 500+ startups with dedicated resources, partnerships and events.
Show more
Investment focus
  • Software, Artificial Intelligence, Robotics
  • Seed, Series A, Pre-Seed
  • United States, France, United Kingdom
Portfolio highlights
  • Cowboy — Meet Cowboy, the connected electric bike for urban riders. With an intuitive motor to sense your pedaling force and a companion app in the cockpit to guide your ride, tune into a newfound freedom in the city.
  • atmio — atmio helps natural gas operations to find, fix and report methane emissions easily.
  • Orakl Oncology — Cultivated with love by the Orakl team.
Pace Ventures VC Fund · Berlin, Berlin, Germany · 4 investments in the past 12 months
Investing at the intersection of climate and health.
Show more
Investment focus
  • Software, Biotechnology, Information Technology
  • Seed, Funding Round, Pre-Seed
  • United States, Germany, Austria
Portfolio highlights
  • Clearly.Earth — Decarbonise your fleet whilst saving costs
  • Turnover Labs — Turnover Labs strives to decarbonize the chemical production business and transform how the world generates petrochemicals.
  • Dunia Innovation — Catalysing the energy transition.
OrbiMed VC Fund · New York, New York, United States · 45 investments in the past 12 months
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • United States, China, Israel
Portfolio highlights
  • Rapt Therapeutics — RAPT Therapeutics is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. Utilizing its proprietary discovery and development engine, the company is developing highly selectivesmall molecules designed to modulate the critical immune responses underlying these diseases. In its first four years since inception, RAPT has discovered and advanced two unique drug candidates, each targeting C-C motif chemokine receptor 4. The company’s lead oncology drug candidate, FLX475, reached the clinic in just two and a half years with its lead inflammation drug candidate, RPT193, also in the clinic. The company is also pursuing a range of targets, including general control nonderepressible 2 and hematopoietic progenitor kinase 1, that are in the discovery stage of development.
  • Verdiva Bio — Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related complications achieve better outcomes via more patient-friendly therapeutic options.
  • Aviceda Therapeutics — Aviceda Therapeutics is a late-stage, pre-clinical biotech company developing drugs for treating glyco-immune diseases. The company focuses on the next generation of immunomodulators by harnessing the power of glycobiology to address the innate immune system and chronic non-resolving inflammation specifically and profoundly. A combination ofcutting-edge technologies and deep biological insights form Aviceda’s engine of transformative product creation.Aviceda uses its cell-based high-throughput screening (HTS) platform to rapidly screen, select, and optimize ligands based on maximum affinity and specificity for each different type of innate immune cell. . The company's products are for eye diseases, fibrosis, neurology, and oncology, for eye diseases like AVD-104, AVD-302, AVD-401 for dry eye, diabetic retinopathy, and retinoblastoma respectively AVD-601, AVD-701 and AVD-801 for oncology, neurology, and fibrosis respectively.
Biogena VC Fund · Salzburg, Salzburg, Austria
Biogena develops, produces & markets high-quality dietary supplements.
Show more
Investment focus
  • Food and Beverage, Fitness, Health Care
  • Seed
  • Austria, United States
Portfolio highlights
  • NEOH USA — NEOH USA is a fast growing new food brand from Kirkland, WA and the leader in Crossbars. It satisfies your sweet tooth without the guilt. Crossbars taste as great as a candy bars but are protein bars.
  • Saturo — Saturo is Europe’s first meal replacement product in a bottle, offering balanced and healthy nutrition.
  • Luminous Labs GmbH — Welcome to Luminous Labs - we are one of the leading photobiomodulation and red light therapy companies in Europe. With a strong focus on research and development we are expanding the human health-span with our non-invasive technology. One photon at a time, starting with female fertility and longevity.
Polaris Partners VC Fund · Boston, Massachusetts, United States · 22 investments in the past 12 months
Polaris Partners invests in healthcare and biotechnology companies. Their healthcare portfolio companies' care delivery models include digital health, consumer-centric businesses, patient-provider solutions, data science, and analytics. Their life sciences and biotechnology portfolio companies focus on molecules and platforms, therapeutics,and genomics.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series B, Series A, Series C
  • United States, Singapore, Ireland
Portfolio highlights
  • TRex Bio — TRexBio is a discovery stage biotechnology company leveraging cutting-edge computational biology tools, a focus on human tissue, and expertise in immunobiology to develop revolutionary therapeutics for cancer and inflammatory diseases. Our powerful ‘deep biology’ discovery engine maps human tissue Treg behavior to disease processes, allowing us toidentify and characterize novel targets for therapeutic intervention. Leveraging this platform, we are building a broad portfolio of novel therapies that modulate the immune system to restore human tissue immune homeostasis.
  • Sunbird Bio — Sunbird Bio, a biotech company, is developing protein-based diagnostic tests that empower diagnosis and treatment of Alzheimer's disease, neurological disorders, and early-stage cancer.
  • Candid Therapeutics — Candid Therapeutics is a biotechnology company that focuses on the treatment of a range of immunological conditions.
Lansdowne Investment Company Cyprus VC Fund
Lansdowne Investment Company Cyprus
Show more
Investment focus
  • Life Science, Biotechnology, Semiconductor
  • Seed
  • Austria
Portfolio highlights
  • Sarcura — Sarcura GmbH is an Austrian deep-tech startup developing an instrument platform for the industrial manufacturing of advanced cell therapies. Our platform combines silicon chip technology and microfluidic processing to enable real-time process control and manipulation on a cellular level, enabling a fully automated and modular manufacturing system..
Investors by industry
Investors by country
VC (Venture Capital) Funds in Austria by industry